April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Effect of intravitreal ranibizumab on retinal oxygen saturation in diabetic macular edema - a pilot study
Author Affiliations & Notes
  • Christoph Mitsch
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Katharina Kriechbaum
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Katharina Kefer
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Magdalena Baratsits
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Sonja Gudrun Prager
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Andreas Pollreisz
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Christoph D Scholda
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Ursula Schmidt-Erfurth
    Ophthalmology and Optometrics, Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships Christoph Mitsch, None; Katharina Kriechbaum, None; Katharina Kefer, None; Magdalena Baratsits, None; Sonja Prager, None; Andreas Pollreisz, None; Christoph Scholda, None; Ursula Schmidt-Erfurth, Alcon (C), Bayer (C), Böhringer (C), Novartis (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1770. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christoph Mitsch, Katharina Kriechbaum, Katharina Kefer, Magdalena Baratsits, Sonja Gudrun Prager, Andreas Pollreisz, Christoph D Scholda, Ursula Schmidt-Erfurth, ; Effect of intravitreal ranibizumab on retinal oxygen saturation in diabetic macular edema - a pilot study. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1770.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the effect of intravitreal ranibizumab on the oxygen saturation in retinal vasculature of patients with diabetic macular edema (DME)

Methods: In 15 eyes of 15 consecutive patients with DME indicated to receive intravitreal injections of 0.5ml ranibizumab, we performed automatic retinal oximetry (Oxymap Inc., Reykjavik, Iceland) in the treated and the non-treated eye 15 minutes prior to and 15 minutes after intravitreal injection. The oxygen saturations in retinal arteries and veins was determined. Vessel segments of first or second degree were selected. The same segment was analysed before and after the injection. Oximetry data were compared by paired two-tailed t-test. The same examinations were performed in the untreated eye of the same patients.

Results: Intravitreal administration of ranibizumab did not alter the arterial hemoglobin saturation with oxygen (103.8 ± 9.7% prior to the injection and 104.9 ± 25.4% after the procedure, p = 0.853). The mean venous hemoglobin saturation with oxygen did not change significantly after intra-vitreal injection (63.7 ± 9.6% to 59.6 ± 7.9%, p = 0.168). In untreated eyes, arterial hemoglobin saturation with oxygen did not vary significantly (101.6 ± 5.2% prior to the injection of the other eye and 101.1 ± 5.4% after the procedure, p = 0.763). Consistently, the mean venous hemoglobin saturation with oxygen remained unchanged (67.7 ± 6.3% to 66.0 ± 8.1%, p = 0.262).

Conclusions: Oxygen saturation in retinal vessels of DME eyes is not altered significantly after intravitreal injection of ranibizumab.

Keywords: 635 oxygen • 688 retina • 561 injection  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×